Matches in SemOpenAlex for { <https://semopenalex.org/work/W2741832834> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2741832834 abstract "RUNX1 is a transcription factor involved in normal and malignant hematopoiesis. Somatic mutations in RUNX1 (mtRUNX1) have been documented in de novo and secondary AML (10%), MDS (~10%) and CMML (up to 37%). Germ-line, mono-allelic mutations and deletions in RUNX1 cause the highly-penetrant (~40%) autosomal dominant, Familial Platelet Disorder with a propensity to Myeloid Malignancy (FPD-MM). The majority of mtRUNX1 are missense mutations, large deletions or truncation-mutations in the DNA-binding ‘RUNT’ homology domain, or in the C-terminal transactivation domain. These mutations behave mostly as loss of function mutations, associated with relative resistance to standard chemotherapy and an unfavorable prognosis in AML. This highlights an unmet need to develop and test novel targeted therapies for AML due to germ-line or somatic mtRUNX1. In the present studies, we demonstrate that shRNA-mediated knockdown of mutant and wild-type RUNX1 repressed its target genes MYC, PU.1 and MPO (myeloperoxidase), as well as inhibited growth and induced apoptosis of AML cells expressing mtRUNX1 (OCI-AML5 and Mono-Mac-1). Ex vivo depletion of RUNX1 abrogated the leukemia initiating potential of OCI-AML5 cells. After engraftment, tetracycline-inducible shRNA-mediated in vivo knockdown of RUNX1, as compared to the non-induced controls, enhanced survival of the immune-depleted (NSG) mice engrafted with OCI-AML5 cells. RUNX1 transcription is driven by the BET protein BRD4-occupied super enhancer in the first intron of the RUNX1 gene. A heat map of Hi-C interaction scores within the RUNX1 TAD (topology-associated domain) showed triangle-shaped regions of high interaction, with CTCF binding sites defining the TAD boundaries, anchoring a loop that separates the RUNX1 TAD from other TADs. Consistent with this, our findings show that, shRNA-mediated depletion of BRD4 or treatment with BET protein (BETP) inhibitor (BETi) OTX015 reduced BRD4 occupancy at the enhancer and promoter of RUNX1. This was associated with depletion of RUNX1 and its target-gene expressions and apoptosis of cultured and patient-derived (PD), primary AML blast progenitor cells (BPCs). Additionally, treatment of NSG mice engrafted with luciferase-transduced OCI-AML5 cells with OTX015 (50 mg/kg/day X 5 days, for 3 weeks) reduced the AML burden and significantly improved their survival (p Citation Format: Christopher P. Mill, Courtney DiNardo, Warren C. Fiskus, Dyana T. Saenz, Baohua Sun, Agnieszka J. Nowak, Misun Kim, Mark Routbort, Koichi Takahashi, Kapil N. Bhalla. Novel and effective RUNX1-targeted therapy for AML expressing RUNX1 mutation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr LB-081. doi:10.1158/1538-7445.AM2017-LB-081" @default.
- W2741832834 created "2017-08-08" @default.
- W2741832834 creator A5000534025 @default.
- W2741832834 creator A5010786159 @default.
- W2741832834 creator A5013802454 @default.
- W2741832834 creator A5026519458 @default.
- W2741832834 creator A5038483388 @default.
- W2741832834 creator A5045943632 @default.
- W2741832834 creator A5051949215 @default.
- W2741832834 creator A5056040915 @default.
- W2741832834 creator A5067678169 @default.
- W2741832834 creator A5079069209 @default.
- W2741832834 date "2017-07-01" @default.
- W2741832834 modified "2023-09-27" @default.
- W2741832834 title "Abstract LB-081: Novel and effective RUNX1-targeted therapy for AML expressing RUNX1 mutation" @default.
- W2741832834 doi "https://doi.org/10.1158/1538-7445.am2017-lb-081" @default.
- W2741832834 hasPublicationYear "2017" @default.
- W2741832834 type Work @default.
- W2741832834 sameAs 2741832834 @default.
- W2741832834 citedByCount "0" @default.
- W2741832834 crossrefType "proceedings-article" @default.
- W2741832834 hasAuthorship W2741832834A5000534025 @default.
- W2741832834 hasAuthorship W2741832834A5010786159 @default.
- W2741832834 hasAuthorship W2741832834A5013802454 @default.
- W2741832834 hasAuthorship W2741832834A5026519458 @default.
- W2741832834 hasAuthorship W2741832834A5038483388 @default.
- W2741832834 hasAuthorship W2741832834A5045943632 @default.
- W2741832834 hasAuthorship W2741832834A5051949215 @default.
- W2741832834 hasAuthorship W2741832834A5056040915 @default.
- W2741832834 hasAuthorship W2741832834A5067678169 @default.
- W2741832834 hasAuthorship W2741832834A5079069209 @default.
- W2741832834 hasConcept C104317684 @default.
- W2741832834 hasConcept C109159458 @default.
- W2741832834 hasConcept C134305767 @default.
- W2741832834 hasConcept C153911025 @default.
- W2741832834 hasConcept C173396325 @default.
- W2741832834 hasConcept C203014093 @default.
- W2741832834 hasConcept C2778193527 @default.
- W2741832834 hasConcept C28328180 @default.
- W2741832834 hasConcept C2910090564 @default.
- W2741832834 hasConcept C501734568 @default.
- W2741832834 hasConcept C502942594 @default.
- W2741832834 hasConcept C54355233 @default.
- W2741832834 hasConcept C75563809 @default.
- W2741832834 hasConcept C86803240 @default.
- W2741832834 hasConcept C89560881 @default.
- W2741832834 hasConceptScore W2741832834C104317684 @default.
- W2741832834 hasConceptScore W2741832834C109159458 @default.
- W2741832834 hasConceptScore W2741832834C134305767 @default.
- W2741832834 hasConceptScore W2741832834C153911025 @default.
- W2741832834 hasConceptScore W2741832834C173396325 @default.
- W2741832834 hasConceptScore W2741832834C203014093 @default.
- W2741832834 hasConceptScore W2741832834C2778193527 @default.
- W2741832834 hasConceptScore W2741832834C28328180 @default.
- W2741832834 hasConceptScore W2741832834C2910090564 @default.
- W2741832834 hasConceptScore W2741832834C501734568 @default.
- W2741832834 hasConceptScore W2741832834C502942594 @default.
- W2741832834 hasConceptScore W2741832834C54355233 @default.
- W2741832834 hasConceptScore W2741832834C75563809 @default.
- W2741832834 hasConceptScore W2741832834C86803240 @default.
- W2741832834 hasConceptScore W2741832834C89560881 @default.
- W2741832834 hasLocation W27418328341 @default.
- W2741832834 hasOpenAccess W2741832834 @default.
- W2741832834 hasPrimaryLocation W27418328341 @default.
- W2741832834 hasRelatedWork W2052372808 @default.
- W2741832834 hasRelatedWork W2055922911 @default.
- W2741832834 hasRelatedWork W2161371146 @default.
- W2741832834 hasRelatedWork W2173251312 @default.
- W2741832834 hasRelatedWork W2531799057 @default.
- W2741832834 hasRelatedWork W2556922984 @default.
- W2741832834 hasRelatedWork W2579386761 @default.
- W2741832834 hasRelatedWork W2582520528 @default.
- W2741832834 hasRelatedWork W2940527079 @default.
- W2741832834 hasRelatedWork W2943967571 @default.
- W2741832834 hasRelatedWork W2954328413 @default.
- W2741832834 hasRelatedWork W2956766018 @default.
- W2741832834 hasRelatedWork W2979311420 @default.
- W2741832834 hasRelatedWork W2980523392 @default.
- W2741832834 hasRelatedWork W2981751505 @default.
- W2741832834 hasRelatedWork W3048709867 @default.
- W2741832834 hasRelatedWork W3081126632 @default.
- W2741832834 hasRelatedWork W3133226416 @default.
- W2741832834 hasRelatedWork W3147240941 @default.
- W2741832834 hasRelatedWork W3205746518 @default.
- W2741832834 isParatext "false" @default.
- W2741832834 isRetracted "false" @default.
- W2741832834 magId "2741832834" @default.
- W2741832834 workType "article" @default.